AKAN
Price
$1.29
Change
-$0.04 (-3.01%)
Updated
Nov 13 closing price
Capitalization
939.49K
Intraday BUY SELL Signals
CGC
Price
$1.10
Change
-$0.09 (-7.56%)
Updated
Nov 13 closing price
Capitalization
373.69M
84 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

AKAN vs CGC

Header iconAKAN vs CGC Comparison
Open Charts AKAN vs CGCBanner chart's image
Akanda
Price$1.29
Change-$0.04 (-3.01%)
Volume$1.39M
Capitalization939.49K
Canopy Growth
Price$1.10
Change-$0.09 (-7.56%)
Volume$24.07M
Capitalization373.69M
AKAN vs CGC Comparison Chart in %
View a ticker or compare two or three
VS
AKAN vs. CGC commentary
Nov 14, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AKAN is a Hold and CGC is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Nov 14, 2025
Stock price -- (AKAN: $1.29 vs. CGC: $1.19)
Brand notoriety: AKAN: Not notable vs. CGC: Notable
Both companies represent the Pharmaceuticals: Generic industry
Current volume relative to the 65-day Moving Average: AKAN: 97% vs. CGC: 91%
Market capitalization -- AKAN: $939.49K vs. CGC: $373.69M
AKAN [@Pharmaceuticals: Generic] is valued at $939.49K. CGC’s [@Pharmaceuticals: Generic] market capitalization is $373.69M. The market cap for tickers in the [@Pharmaceuticals: Generic] industry ranges from $63.66B to $0. The average market capitalization across the [@Pharmaceuticals: Generic] industry is $4.14B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AKAN’s FA Score shows that 0 FA rating(s) are green whileCGC’s FA Score has 0 green FA rating(s).

  • AKAN’s FA Score: 0 green, 5 red.
  • CGC’s FA Score: 0 green, 5 red.
According to our system of comparison, AKAN is a better buy in the long-term than CGC.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AKAN’s TA Score shows that 4 TA indicator(s) are bullish while CGC’s TA Score has 4 bullish TA indicator(s).

  • AKAN’s TA Score: 4 bullish, 3 bearish.
  • CGC’s TA Score: 4 bullish, 7 bearish.
According to our system of comparison, AKAN is a better buy in the short-term than CGC.

Price Growth

AKAN (@Pharmaceuticals: Generic) experienced а -3.01% price change this week, while CGC (@Pharmaceuticals: Generic) price change was +4.39% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was +1.08%. For the same industry, the average monthly price growth was -3.24%, and the average quarterly price growth was +32.16%.

Reported Earning Dates

CGC is expected to report earnings on Feb 06, 2026.

Industries' Descriptions

@Pharmaceuticals: Generic (+1.08% weekly)

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CGC($374M) has a higher market cap than AKAN($939K). CGC YTD gains are higher at: -56.569 vs. AKAN (-74.200). AKAN has higher annual earnings (EBITDA): -3.03M vs. CGC (-410.31M). CGC has more cash in the bank: 144M vs. AKAN (3.84M). AKAN has less debt than CGC: AKAN (353K) vs CGC (328M). CGC has higher revenues than AKAN: CGC (275M) vs AKAN (837K).
AKANCGCAKAN / CGC
Capitalization939K374M0%
EBITDA-3.03M-410.31M1%
Gain YTD-74.200-56.569131%
P/E Ratio0.04N/A-
Revenue837K275M0%
Total Cash3.84M144M3%
Total Debt353K328M0%
FUNDAMENTALS RATINGS
CGC: Fundamental Ratings
CGC
OUTLOOK RATING
1..100
60
VALUATION
overvalued / fair valued / undervalued
1..100
94
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
98
PRICE GROWTH RATING
1..100
87
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
AKANCGC
RSI
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
71%
Stochastic
ODDS (%)
N/A
Bullish Trend 2 days ago
73%
Momentum
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
89%
MACD
ODDS (%)
Bullish Trend 2 days ago
76%
Bearish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
76%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
Advances
ODDS (%)
Bullish Trend about 1 month ago
84%
Bullish Trend 4 days ago
79%
Declines
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
72%
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
AKAN
Daily Signal:
Gain/Loss:
CGC
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
FFWM5.06-0.02
-0.39%
First Foundation
BHFAM11.50-0.30
-2.54%
Brighthouse Financial
CR185.71-5.27
-2.76%
Crane Company
EYE23.67-1.07
-4.32%
National Vision Holdings
ACRV2.07-0.21
-9.21%
Acrivon Therapeutics

CGC and

Correlation & Price change

A.I.dvisor indicates that over the last year, CGC has been closely correlated with SNDL. These tickers have moved in lockstep 77% of the time. This A.I.-generated data suggests there is a high statistical probability that if CGC jumps, then SNDL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CGC
1D Price
Change %
CGC100%
-0.83%
SNDL - CGC
77%
Closely correlated
-3.24%
ACB - CGC
66%
Loosely correlated
-0.44%
TLRY - CGC
63%
Loosely correlated
-4.65%
OGI - CGC
61%
Loosely correlated
-1.83%
CRON - CGC
58%
Loosely correlated
+0.79%
More